- Hospitalized cancer patients with nosocomial COVID-19 have higher mortality rates than those with community-acquired COVID-19.
Why this matters
- The findings emphasize that patients with cancer should be treated in COVID-19-free zones.
- The study included 250 adults and 3 children with COVID-19 and cancer.
- 81% of patients had community-acquired COVID-19 and 19% had nosocomial COVID-19.
- Funding: None disclosed.
- At a median follow-up of 23 days, the overall mortality rate was 28%.
- The all-cause mortality rate in patients with nosocomial COVID-19 was significantly higher than in patients with community-acquired COVID-19 (47% vs 23%).
- The median OS was 27 days in the nosocomial group vs 71 days in the community-acquired group (HR, 2.2; P=.002).
- No significant differences were seen in the nosocomial vs community-acquired groups for:
- Oxygen requirements (43% vs 47%);
- Intensive care admission (13% vs 11%);
- Need for mechanical ventilation (6% vs 5%); and
- Length of hospital stay (median, 9.5 vs 8.5 days).
- Observational design.